India to Ethiopia: Trimethoprim Export Trade Route

The India to Ethiopia Trimethoprim corridor is one of India's established pharmaceutical export routes, with 74 shipments documented worth a combined $2.3M USD. The route is dominated by LEBEN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's trimethoprim manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $31.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with trimethoprim's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 20.0%, placing it at rank #16 among India's top trimethoprim export destinations globally.

On the import side, key buyers of Indian trimethoprim in Ethiopia include ETHIOPIAN PHARMACEUTICALS SUPPLY,, ETHIOPIAN PHARMACEUTICALS SUPPLY, TO THE ORDER OF and 14 others. ETHIOPIAN PHARMACEUTICALS SUPPLY, is the single largest importer with 15 shipments valued at $494.4K USD.

India's trimethoprim exports to Ethiopia are driven primarily by a handful of large-scale manufacturers. LEBEN LABORATORIES PRIVATE LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Ethiopia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — LEBEN LABORATORIES PRIVATE LIMITED, MEDICAMEN BIOTECH LIMITED, MEDICAMEN BIOTECH LIMITED — together account for 91% of total trade value on this route. The average shipment value of $31.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as sulphamethoxazole+trimethoprim (800 mg+160mg) tablet 100 x 10 pac (l-trim ds tablet ) pharmaceutical products- medi.nos and sulphamethoxazole+trimethoprim (800 mg+1 , suggesting that buyers in Ethiopia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ETHIOPIAN PHARMACEUTICALS SUPPLY, is the largest importer with 15 shipments worth $494.4K USD — representing 21% of all trimethoprim imports from India on this route. A total of 17 buyers are active on this corridor.